Dr David Cabrera
David is currently working to engineer magnetic nanoparticles (MNPs) as a new platform to treat venous thromboembolism (VTE). VTE is a condition in which unwanted blood clots formed in leg veins travel through the bloodstream and lodge in the lungs, which may lead to death and important disabilities.
Current treatment of venous thromboembolism involves the systemic administration of either anticoagulants to prevent further thrombus growth, or thrombolytic enzymes to try to lyse the clot; yet systemic circulation of both pharmacological agents often leads to major unwanted bleeding in patients. By using MNPs and their unique the nano-chemical and thermal properties, David expects to significantly reduce secondary effects associated to pharmacological treatments of VTE, as well as boost their efficacy.